Navigation Links
Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
Date:7/22/2013

om.

About Lotus Clinical Research, LLC

Established in 2001, Lotus Clinical Research, LLC operates a 40 bed Phase I-3 privately owned research unit located on the 675–bed Huntington Hospital campus in Pasadena, California.  We have a significant therapeutic expertise in research studies involving acute pain, chronic pain and opioid induced constipation.  In addition to functioning as a research site, we provide analgesic protocol optimization services to industry sponsors which consist of: training tools for research subjects, educational materials for analgesic investigators/study staff, site identification/selection and protocol writing.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause Imprimis' results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in Imprimis' filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q filed with the SEC. Such documents may be read free of charge on the SEC's web site at www.sec.gov. Undue reliance should not be placed on forward looking statements, which speak only as of the date they are made. Except as required by law, Imprimis undertakes no 
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Rock Creek Pharmaceuticals, Inc., ... on chronic inflammatory disease and neurologic disorders, announced today ... with anatabine citrate, the Company,s lead compound. Results from ... anatabine citrate can significantly inhibit the activation of inflammatory ... is developing this compound in a Phase 1 clinical ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... a new study Stationary Oxygen Concentrators Market ... markets are poised to achieve continuing growth as the ... develop COPD and other respiratory conditions where oxygen is ... a dramatic manner. Portable devices have become affordable and ...
(Date:7/1/2015)... DIEGO , July 1, 2015 OncoSec Medical ... intratumoral cancer immunotherapies, today announced that CEO and President ... celebration of the Company,s listing to The Nasdaq Stock Market ... Nasdaq MarketSite in New York City . ... employees, investors, and stakeholders, we are honored to open the ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3
... releases of Elekta,s XiO® treatment planning system and Focal ... and deliver radiation therapy plans more efficiently. ... Therapy (IMRT) segmentation algorithm, fluence map smoothing and DICOM ... for contouring, enabling clinicians to contour anatomy faster and ...
... the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... 2011-2012 Fluzone® Influenza Virus Vaccine in the U.S. This shipment ... influenza vaccine the company plans to deliver to the U.S. ... producer of influenza vaccine in the U.S., supplying more than ...
Cached Medicine Technology:Latest Releases of Elekta's XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 3Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 4Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 5Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 6
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today ... Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which is located ... production base, began in May 2014. After commissioning, commercial production is expected to ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... The Collaborative ... the New York Community Trust. The grant will allow CCF to improve quality of ... practices. , CCF was formed to respond to many changes in New York’s Medicaid ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Hospital Corporation of America (HCA), as it further expands its Strategic Alliance Partnership ... , With this new partnership, OncLive’s editorial and marketing teams will collaborate with ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... training leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso ... Network (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4
... ABAX ), a medical products company manufacturing point-of-care blood,analysis ... 2008. , , Highlights for the third quarter ... $27.0 million, up 5% over last year,s comparable quarter., ... over last year,s, comparable quarter., ...
... underlying trait, but connection is vague, study says , , ... doesn,t decrease a woman,s risk of preterm birth, according ... a link. , As a result of those earlier ... pregnant women undergo dental "deep cleaning" (scaling and root ...
... and PALO ALTO, Calif., Jan. 29 ,Diagnosoft, Inc., ... that assists in diagnosis, staging and therapeutic monitoring ... $4 million in Series B,financing led by Technology ... intends to use the new capital to support ...
... 29 Mylan Inc. (Nasdaq: MYL ) today ... issuance, the company has declared its quarterly dividend of $16.25 ... and a liquidation preference of $1,000.00 per share) payable on ... as of Feb. 1, 2009.Mylan Inc., which provides products to ...
... Meditation Center of Los Angeles will present a program featuring ... an ancient practice of physical fitness, which has been used ... youthfulness in the body. The Level 1 & 2 ... Center for the Arts in Eagle Rock.The healing Taoist practice ...
... On February 19, 2009 at Noon CT, compliance and ... and Catholic Healthcare West will be discussing how companies ... stagnant or declining budgets. They will be participating ... and Ethics, Five Leaders, Five Industries, Ideas for Your ...
Cached Medicine News:Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 2Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 3Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 4Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 5Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 6Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 7Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 8Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 9Health News:Gum Disease Treatment Doesn't Cut Preterm Birth Risk 2Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 2Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 3Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 4Health News:World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8 2Health News:Five Leaders From Five Industries to Tackle Concerns Over the Economy and Its Impact on Compliance and Ethics During Society of Corporate Compliance and Ethics and Health Care Compliance Association Audio/Web Conference 2
Industry leader in the design and manufacturing of GP Lenses. Abba holds the CLMA seal of excellence award....
... data collection and management ... multiple store environment. Home ... office with the stores ... and inventory reporting, recalls ...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... SDS Octoplus Ordering/Dispensing has gained recognition as ... lens ordering system. It enables opticians to ... using SDS electronic communications technology. When used ... or 3D frame tracers, lens shapes are ...
Medicine Products: